IOMERON 350

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

IOMEPROL

Disponible desde:

DEXCEL LTD, ISRAEL

Código ATC:

V08AB

formulario farmacéutico:

SOLUTION FOR INJECTION

Composición:

IOMEPROL 714.4 MG/ML

Vía de administración:

I.V, INTRA-ARTERIAL

tipo de receta:

Required

Fabricado por:

BRACCO IMAGING S.P.A., ITALY

Grupo terapéutico:

WATERSOLUBLE, NEPHROTROPIC, LOW OSMOLAR X-RAY CONTRAST MEDIA

indicaciones terapéuticas:

Contrast medium for diagnostic radiography. Intravenous urography (in adults and pediatrics), CT (body), intravenous DSA, conventional angiography, intraarterial DSA, angiocardiography (in adults and pediatrics), conventional selective coronary arteriography, interventional coronary arteriography , arthrography, hysterosalpingography, fistulography, galactography, retrograde chloangiography, dacryocystography, sialography.

Fecha de autorización:

2021-12-31

Información para el usuario

_ _
ינוי
2022
IOMERON 300, 350, 400 MG, SOLUTION FOR INJECTION
,דבכנ יאופר תווצ
תרבח
מ"עב לסקד
ןוכדע לע םכעידוהל תשקבמ
ןולעב
אפורל
רישכתה לש
םי
:
א
ןורמוי
300
,
350
,
400
.
העדוהב
וז
םינוכדעה םיטרופמ
דבלב יתוחיטבה עדימב הרמחה םיווהמה
.
ןייעל שי ,אלמ עדימל
ןולעב
.
אפורל ןולעה
ופורתה רגאמב םוסרפל חלשנ
לבקל ןתינו תואירבה דרשמ רתאבש ת
ו
ספדומ
לעבל היינפ י"ע
:םושירה
לסקד
מ"עב
לסקד 'חר ,
1
אביקע רוא ,
3060000
:'לט ,לארשי ,
04-6364000
. בכרה
:רישכתה
.
respectively
iomeprol 61.24 g, 71.44 g, 81.65 g
Each 100 ml of solution contains
יוותה
תו
רשואמ
ו
:ת
Contrast medium for diagnostic radiology.
IOMERON 300: Intravenous urography (in adults and paediatrics),
peripheral phlebography,
CT (brain and body), cavernosography, intravenous DSA, conventional
angiography,
intraarterial DSA, angiocardiography (in adults and paediatrics),
conventional selective
coronary arteriography, interventional coronary arteriography, ERCP,
arthrography,
hysterosalpingography, fistulography, discography, galactography,
chloangiography,
dacryocystography, sialography, retrograde urethrography, retrograde
pyelo-ureterography.
IOMERON 350:
Intravenous urography (in adults and paediatrics), CT (body),
intravenous
DSA, conventional angiography, intraarterial DSA, angiocardiography
(in adults and
paediatrics), conventional selective coronary arteriography,
interventional coronary
arteriography, arthrography, hysterosalpingography, fistulography,
galactography,
retrograde cholangiography, dacryocystography, sialography.
IOMERON 400: Intravenous urography (in adults including those with
renal impairment or
diabetes), CT (body), conventional angiography, intraarterial DSA,
angiocardiography (in
adults and paediatrics), conventional selective coronary
arteriography, interventional
co

Ficha técnica

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
IOMERON
® 300
IOMERON
® 350
IOMERON
® 400
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
IOMERON
®
300
100 ml of solution contains:
Active ingredient: Iomeprol: 61.24 g
IOMERON
®
350
100 ml of solution contains:
Active ingredient: Iomeprol: 71.44 g
IOMERON
®
400
100 ml of solution contains:
Active ingredient: Iomeprol: 81.65 g
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
IOMEPROL,
N,
N’
-bis(2,
3-dihydroxypropyl)-5[(hydroxyacetyl)methylamino]-2,
4,
6-triiodo-1,
3-
benzenedicarboxamide, the active component of lomeron
®
, is a triiodinated, non-ionic, water soluble,
nephrotropic, low-osmolality X-ray contrast medium with a molecular
weight of 777.09, formulations of which
yield contrast media of particularly low osmolality and viscosity in
comparison with other non-ionic media.
lomeprol has been formulated in a wide range of concentrations (up to
400 mg iodine/ml). All have proved to
be extremely stable both to heat sterilization and prolonged room
temperature storage, without the chelator
(EDTA salt) required by other contrast agents.
Solution for injection displaying the following physico-chemical
characteristics by Iodine strengths as
below:
_Iodine _
_concentration _
_mgI/mL _
_Osmolality _
_mOsmol/kg water _
_(x _

_ s_

_t95)* _
_Viscosity _
_mPa_

_s _
_(x _

_ s_

_t95)* _
_ _
_37° C _
_20°C _
_37° C _
300
521

24
8.1

0.7
4.5

0.4
350
618

29
14.5

1.1
7.5

0.6
400
726

34
27.5

2.3
12.6

1.1
*Steam pressure method
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Contrast medium for diagnostic radiology.
IOMERON 300
Intravenous urography (in adults and paediatrics), peripheral
phlebography, CT (brain and
body), cavernosography, intravenous DSA, conventional angiography,
intraarterial DSA,
angiocardiography (in adults and paediatrics), conventional selective
coronary
arteriography, interventional coronary arteriography, ERCP,
arthrography,
hysterosalpingograph